kabutan

MEDINET Co., Ltd.(2370) Summary

2370
TSE Growth
MEDINET Co., Ltd.
31
JPY
0
(0.00%)
Jan 29, 1:38 pm JST
0.20
USD
Jan 28, 11:38 pm EST
Result
PTS
outside of trading hours
31
Jan 29, 1:39 pm JST
Summary Chart Historical News Financial Result
PER
PBR
2.17
Yield
ー%
Margin Trading Ratio
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
33 JPY 0.21 USD
Previous Close Jan 28
31 JPY 0.20 USD
High Jan 29, 9:00 am
33 JPY 0.21 USD
Low Jan 29, 12:32 pm
30 JPY 0.19 USD
Volume
3,417,200
Trading Value
0.11B JPY 0.70M USD
VWAP
31.55 JPY 0.21 USD
Minimum Trading Value
3,100 JPY 20 USD
Market Cap
8.21B JPY 0.05B USD
Number of Trades
253
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Mid
1-Year Average
156
1-Year High Jun 24, 2025
1,875
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 0 11,483,300
Jan 16, 2026 0 11,444,200
Jan 9, 2026 0 11,422,500
Dec 26, 2025 0 11,354,000
Dec 19, 2025 0 11,811,600
Company Profile
MEDINET Co., Ltd. is a venture business originating from the Institute of Medical Science at the University of Tokyo. The company provides comprehensive services for cancer immunotherapy and is also involved in pharmaceutical development.
Sector
Services
MEDINET Co., Ltd. operates in the cell processing industry and regenerative medicine product business. In the cell processing industry, the company manufactures specific cell products for medical institutions, contracts the production of clinical and trial cell products for companies and universities, manages cell culture processing facilities, and provides dispatch and education systems for cell processing technicians. In the regenerative medicine product business, MEDINET Co., Ltd. aims to obtain manufacturing and marketing approval for regenerative medicine products through joint research with universities and other institutions.